Palmitoyl Pentapeptide-4 (Matrixyl)

Mechanism

One of the most proven anti-aging skincare peptides. It's a fragment of collagen that signals your skin to make more collagen, elastin, and other structural proteins. Applied topically in serums and creams. Clinical studies show it can reduce wrinkle depth comparably to retinol without the irritation.

Effects

## Integumentary System — Collagen Stimulation [Tier 2 — Good Human Data for a Cosmeceutical] Matrixyl (Palmitoyl Pentapeptide-4, Pal-KTTKS) is a lipopeptide consisting of the pentapeptide KTTKS (Lys-Thr-Thr-Lys-Ser) conjugated to palmitic acid for enhanced skin penetration. KTTKS is a fragment of the procollagen I C-terminal propeptide — a natural byproduct of collagen synthesis. When collagen is degraded by matrix metalloproteinases (MMPs) during aging and UV damage, KTTKS fragments signal fibroblasts to produce more collagen as a repair response (matrikine signaling). Matrixyl harnesses this feedback loop: by delivering the KTTKS signal exogenously, it stimulates fibroblasts to upregulate collagen I (by 100-300% in vitro), collagen III, collagen IV, fibronectin, and hyaluronic acid production. The palmitic acid lipid tail enables stratum corneum penetration that the native peptide cannot achieve alone. ## Skin Architecture — Multi-Layer Effects [Tier 2 — Clinical/In Vitro] Matrixyl does not just stimulate collagen — it promotes a coordinated ECM remodeling response. Clinical studies using full-thickness skin biopsies after 6 months of topical Matrixyl showed increased dermal thickness, increased collagen density (by 14-22%), and improved organization of collagen fibrils. Epidermal thickness also increased, consistent with improved basement membrane integrity via collagen IV and laminin stimulation.

Practitioner Guide

## Practical Formulation Guide — Matrixyl (The Gold Standard Cosmetic Peptide) ### Why Matrixyl Is the Benchmark Matrixyl is the most studied and commercially successful topical anti-aging peptide. It has the strongest evidence base of any cosmeceutical peptide, with data from Sederma, independent academic studies, and Procter & Gamble (who licensed it for Olay Regenerist, one of the best-selling anti-aging products in history). ### Effective Concentrations - **Minimum effective:** 2% of commercial Matrixyl solution (100 ppm active Pal-KTTKS) - **Optimal:** 4-8% of commercial solution (200-400 ppm active peptide) - **Used in clinical studies:** 100 ppm Pal-KTTKS in cream base ### Formulation Considerations - **pH:** Stable at pH 5.0-7.0. Optimal around pH 5.5-6.0. - **Solubility:** The palmitic acid tail makes Matrixyl amphiphilic — it is soluble in both aqueous and emulsion systems. Works in serums, creams, and lotions. - **Heat stability:** Can tolerate brief exposure to 60-70°C during emulsification. More heat-stable than many peptides. - **Compatibility:** Excellent compatibility with virtually all cosmetic ingredients and other peptides. Specifically tested and confirmed compatible with: Argireline, Pal-GHK, Pal-Tripeptide-38, niacinamide, retinol, vitamin C (ascorbyl glucoside — NOT pure L-ascorbic acid at low pH), hyaluronic acid, ceramides. - **Incompatibility:** Avoid formulating with strong AHAs below pH 3.5 in the same phase. At very low pH, the peptide bond between palmitic acid and the peptide can hydrolyze over time (affects shelf life more than efficacy at point of use). ### The Matrixyl Family - **Matrixyl (original):** Pal-KTTKS. Collagen I, III stimulation. - **Matrixyl 3000:** Combination of Pal-GHK (Palmitoyl-Tripeptide-1) + Pal-GQPR (Palmitoyl-Tetrapeptide-7). Collagen stimulation + anti-inflammatory. - **Matrixyl Synthe'6:** Pal-VGVAPG (Palmitoyl-Tripeptide-38). Stimulates 6 major ECM components (collagen I, III, IV, fibronectin, hyaluronic acid, laminin 5). - These are different products with different peptide compositions — "Matrixyl" alone refers to the original Pal-KTTKS. ### How to Build a Complete Peptide Serum **Base formulation approach:** 1. Start with water-phase base (purified water, humectants like glycerin 3-5%, sodium hyaluronate 0.1-0.5%) 2. Add peptides to the cooled (<40°C) water phase: Matrixyl solution (4-8%), Argireline solution (10%), any additional peptides 3. Adjust pH to 5.5-6.0 4. Add preservative system (phenoxyethanol 0.8-1.0% + ethylhexylglycerin 0.3%) 5. Optional: add 0.1-0.5% xanthan gum or hydroxyethylcellulose for viscosity **Recommended multi-peptide combinations:** - **Anti-wrinkle focus:** Matrixyl + Argireline + Syn-Ake - **Collagen rebuild:** Matrixyl + Pal-Tripeptide-1 + Hexapeptide-11 - **Complete anti-aging:** Matrixyl Synthe'6 + Argireline + Pal-Tripeptide-5 - **Sensitive skin anti-aging:** Matrixyl 3000 (includes anti-inflammatory component) + Calmosensine ### Realistic Expectations (Based on Published Clinical Data) - **2 weeks:** Improved hydration and skin texture. No significant wrinkle reduction yet. - **4 weeks:** Beginning of measurable wrinkle reduction (5-10%). Skin feels smoother. - **8 weeks:** 15-25% reduction in wrinkle depth/volume. Skin appears more "plump" and hydrated. Noticeable in side-by-side photographs. - **12-24 weeks:** Maximum benefit plateau at ~30-40% wrinkle improvement. Dermal collagen density measurably increased on biopsy. Comparable to what low-concentration retinol achieves over similar timeframe. - **Comparison to retinoids:** Matrixyl achieves roughly similar wrinkle reduction to 0.025-0.05% retinol over 3-6 months, but without the irritation, peeling, or photosensitivity. For patients who cannot tolerate retinoids, Matrixyl is the strongest alternative.

Dosing Protocols

Contraindications & Cautions

• hard stop — Under 18 years of age
  Cosmetic peptide protocols not designed for pediatric use.
  Action: Do not provide to individuals under 18.
• caution — Allergy to cosmetic ingredients
  Contact dermatitis or allergic reactions possible. Formulation excipients (including palmitoyl group) may cause sensitization.
  Action: Perform patch test 24-48 hours before full application. Discontinue if irritation occurs.
• caution — Open wounds or broken skin
  Cosmetic peptides are formulated for intact skin only. Do not apply to damaged or inflamed skin.
  Action: Do not apply to broken skin, open wounds, or active dermatitis.
• caution — Pregnancy or breastfeeding
  Limited safety data for topical cosmetic peptides during pregnancy. Systemic absorption is minimal but not fully characterized.
  Action: Consult physician before use during pregnancy or breastfeeding.

Evidence

• Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin

  Robinson LR, Fitzgerald NC, Pieran DG, Mishler SH (2005) — International Journal of Cosmetic Science — PMID: 18492135

  Topical palmitoyl pentapeptide-4 (Matrixyl) significantly reduced fine lines and wrinkles vs vehicle control in a 12-week double-blind split-face study. Profilometry measurements showed statistically significant improvements in wrinkle depth, volume, and density. The peptide stimulates collagen I, III, and IV synthesis as well as fibronectin and glycosaminoglycans in dermal fibroblasts. Comparable efficacy to retinol without irritation.

  moderate

Stacks featuring this peptide

Research Summary

## Tier 1 — Strong Clinical Evidence - The most studied cosmeceutical peptide. Multiple independent and manufacturer-sponsored clinical studies confirm wrinkle reduction. - Robinson et al. (Int J Cosmetic Science, 2005): 100 ppm Pal-KTTKS cream showed statistically significant reduction in wrinkle depth and volume vs. vehicle after 12 weeks (p<0.05) — double-blind RCT. - Full-thickness skin biopsy data (Lintner et al.) demonstrating increased dermal collagen density after 6 months of topical application. - Mechanism (matrikine signaling via KTTKS procollagen fragment) is well-established and independently validated. ## Tier 2 — Moderate Evidence - Comparison studies suggest efficacy similar to retinol 0.05% for wrinkle reduction, without irritation (Gorouhi et al., J Cosmetic Dermatology 2009) - In vitro data showing 100-300% increase in collagen I, III, and IV synthesis in fibroblast cultures - Synergistic effects with other cosmetic peptides (GHK, Argireline) in combination studies ## Tier 3 — Preclinical/Theoretical - Potential wound healing application (accelerated collagen deposition in animal wound models) - Enhanced delivery via nanoparticles/liposomes may significantly improve penetration and efficacy - Possible application in stretch mark prevention/treatment (theoretical, based on collagen stimulation mechanism)